Could extracellular vesicles derived from mesenchymal stem cells be a potential therapy for acute pancreatitis-induced cardiac injury?

Acute pancreatitis (AP) often leads to a high incidence of cardiac injury, posing significant challenges in the treatment of severe AP and contributing to increased mortality rates. Mesenchymal stem cells (MSCs) release bioactive molecules that participate in various inflammatory diseases. Similarly...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Long-Fei, Niu, Ze-Qun, Ren, Song, Pei, Hong-Hong, Gao, Yan-Xia, Feng, Hui, Sun, Jiang-Li, Zhang, Zheng-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Opinion Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401421/
https://www.ncbi.nlm.nih.gov/pubmed/37545754
http://dx.doi.org/10.4252/wjsc.v15.i7.654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401421/
https://www.ncbi.nlm.nih.gov/pubmed/37545754
http://dx.doi.org/10.4252/wjsc.v15.i7.654

Ejemplares similares